NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Tirzepatide from Shanghai Baoju? Mail in a sample (US only) and let us test it.

Test my supply
+7 more ↓
78%
Finnrick rating
#142 of 281 Tirzepatide vendors
24 of 31 classifiable tests passed
customers 4.6★ (32)
methodology · Purity focus
Finnrick analysis · Tirzepatide

Shanghai Baoju's Tirzepatide record is mixed: early purity misses and two major fill misses (+50%, then -48%) cap the rating. The long intervening pass streak is meaningful, but the late underfill makes fill consistency the key detail.

methodology →
vendor intelligence report
Vendor Intelligence Report: Shanghai Baoju

Twin Baoju domains registered seconds apart share a WordPress administrator, while supplier-profile history claims collide with archive and trading-company records. The report maps sales personas, a Zhitai bridge, and a cloaked WhatsApp doorway.

35 pages10 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
93%
12
2
Retatrutide
$0.71
85%
30
3
Tirzepatideselected
$0.42
78%
31
5
Ipamorelin
$0.84
66%
5
6
BPC-157
$0.65
55%
6
7
Tesamorelin
$2.02
51%
5
8
TB-500
$1.70
35%
4
9
KPV
$0.59
15%
3
10
5-Amino-1MQ
$1.86
-
0
11
AOD-9604
$2.76
-
0
12
MOTS-c
-
-
0
13
PT-141
$0.66
-
0
14
Semaglutide
$0.72
-
0
15
Sermorelin
$1.52
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Nov 2025: 79%5 Dec 2025: 75%13 Dec 2025: 71%29 Jan 2026: 75%29 Jan 2026: 76%18 Feb 2026: 70%22 Feb 2026: 66%26 Feb 2026: 67%26 Feb 2026: 64%4 Mar 2026: 60%6 Mar 2026: 61%6 Mar 2026: 63%12 Mar 2026: 64%12 Mar 2026: 65%18 Mar 2026: 67%20 Mar 2026: 68%25 Mar 2026: 69%23 Apr 2026: 71%28 Apr 2026: 72%28 Apr 2026: 73%30 Apr 2026: 74%13 May 2026: 75%27 May 2026: 76%27 May 2026: 77%26 Jun 2026: 78%13 Jul 2026: 78%14 Jul 2026: 79%21 Jul 2026: 80%15 Aug 2026: 80%16 Sep 2026: 78%24 Sep 2026: 78%15 Nov 2026: current 78%79%67%78%Nov 25Nov 26
Showing Tirzepatide tests only
Peptide testing

Ordered Tirzepatide from Shanghai Baoju? Mail in a sample (US only) and let us test it.

Test my supply
Shanghai Baoju Tirzepatide test history
COA-backed lab tests
1-10 of 31

About Shanghai Baoju test results from Finnrick

Shanghai Baoju is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 101 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Shanghai Baoju peptides in this dataset are BPC-157 (6 tests), Cagrilintide (5 tests) and GHK-Cu (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 101 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Tirzepatide from Shanghai Baoju? Mail in a sample (US only) and let us test it.

Test my supply